(Q84510635)
Statements
Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen (English)
Nava Siegelmann-Danieli
Daniel Kurnik
Yossi Lomnicky
Janet Vesterman-Landes
Itzhak Katzir
Martin Bialik